GE HealthCare Technologies revenue and financials

GEHC · NASDAQ · USD

$64.77−1.48%−$0.97

Close · October 6, 2026

In the fiscal year ended December 2025, GE HealthCare Technologies reported revenue of $20.63B (+4.84% year over year). Net income was $2.08B, a net margin of 10.1%.

Annual revenue · 2025: $20.63B
  1. $17.59B2021
  2. $18.34B2022
  3. $19.55B2023
  4. $19.67B2024
  5. $20.63B2025

Fiscal year ending in December. Sources and method on the page Methodology and sources.

At a glance

Revenue growth
+4.84%
2025 vs 2024
Net income growth
+4.57%
2025 vs 2024
Net margin
10.1%
2024: 10.1%

Financial data

Amounts in millions of USD; per-share values in USD; shares in millions.

ItemQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023
Total revenue5,2955,1315,6985,1435,0074,7775,3194,8634,8394,6505,2064,822
Cost of revenue3,1153,1543,4373,1543,0232,7653,0442,8382,8372,7493,0502,887
Gross profit2,1801,9772,2611,9891,9842,0122,2752,0252,0021,9012,1561,935
Selling, general and administrative1,0641,0631,0429669559621,0269289629331,133878
Research and development323345323292302344344316327324315322
Operating income793569896731727706905781713644708735
EBIT793569896731727706905781713644708735
EBITDA9537221,0428798758421,045924862792852888
Interest expense1331156.012812412237.014114114868.0147
Pre-tax income693505821643613692834657578512609636
Income tax11994.021917911310496.0168143124193250
Net income561389589446486564721470428374403375
Net income to common shareholders561389589446486564721470428374403375
Basic EPS1.240.851.290.981.061.231.581.030.940.820.890.82
Diluted EPS1.240.851.290.981.061.231.571.020.930.810.880.82
Average shares (basic)453456456456457457457457457456455455
Average shares (diluted)454457457457458459459459459459458458
Dividend per share0.040.040.040.040.040.040.040.030.030.030.030.03